Guidance change threatens hospital 340B drug discounts
Healthcare
Stay updated with breaking news from Maureen Testoni. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Teva Pharmaceuticals will stop shipping 36 discounted drugs to contract pharmacies in July, citing concerns of a diluted 340B program.
A change in guidance could translate to the loss of tens of millions of dollars in expected annual savings for some hospitals with broad outpatient networks.
Legislation to increase transparency and oversight of the 340B drug discount program was passed by the House Energy and Commerce Committee's Subcommittee on Health.
Johnson, Spanberger Introduce Bipartisan Bill to Protect 340B Program, Prevent Higher Drug Prices Washington, D.C. – Today, U.S. Representatives Dusty Johnson (R-S.D.) and Abigail Spanberger (D-VA-07) introduced a bipartisan bill that would prohibit health insurers and PBMs from discriminating against 340B Drug Pricing Program providers or their contract pharmacies on the basis of their status…